Jasper Therapeutics(JSPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JSPR Jasper Therapeutics

交易中 03-10 09:44:25 EDT

1.39

+0.08

+6.11%

最高1.40	最低1.31	成交量2.13万
今开1.32	昨收1.31	日振幅6.88%
总市值3,890万	流通市值3,171万	总股本2,798万
成交额2.90万	换手率0.09%	流通股本2,281万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"JSPR","market":"US","secType":"STK","nameCN":"Jasper Therapeutics","latestPrice":1.39,"timestamp":1773150257512,"preClose":1.31,"halted":0,"volume":21259,"delay":0,"changeRate":0.061068702290076216,"floatShares":22810300,"shares":27984039,"eps":-5.78681,"marketStatus":"交易中","change":0.08,"latestTime":"03-10 09:44:25 EDT","open":1.32,"high":1.4,"low":1.3099,"amount":28993.640711,"amplitude":0.068779,"askPrice":1.4,"askSize":1000,"bidPrice":1.38,"bidSize":34,"shortable":3,"etf":0,"ttmEps":-5.78681,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.31,"preHourTrading":{"tag":"盘前","latestPrice":1.31,"preClose":1.31,"latestTime":"09:15 EDT","volume":720,"amount":940.296024,"timestamp":1773148507007,"change":0,"changeRate":0,"amplitude":0.015267},"postHourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.31,"latestTime":"19:54 EDT","volume":803,"amount":1060.6,"timestamp":1773100446922,"change":0,"changeRate":0,"amplitude":0.015267},"volumeRatio":0.9741,"impliedVol":1.4998,"impliedVolPercentile":0.6016},"requestUrl":"/m/hq/s/JSPR","defaultTab":"news","newsList":[{"id":"2603276106","title":"Jasper Therapeutics, Inc.盘中异动 大幅拉升5.13%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603276106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603276106?lang=zh_cn&edition=full","pubTime":"2026-01-15 01:49","pubTimestamp":1768412980,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日01时49分，Jasper Therapeutics, Inc.股票出现波动，股价快速拉升5.13%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Alpha Tau Medical Ltd.、Virax Biolabs Group Limited涨幅较大，Briacell Therapeutics Corp.、Clearmind Medicine Inc.、Nrx Pharmaceuticals, Inc.较为活跃，换手率分别为238.19%、78.58%、68.73%，振幅较大的相关个股有Alpha Tau Medical Ltd C/Wts 、Briacell Therapeutics Corp C/Wts 、60 Degrees Pharmaceuticals, Inc.，振幅分别为56.54%、46.51%、39.81%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115014941a71b1fb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115014941a71b1fb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","JSPR","BK4007","BK4139"],"gpt_icon":0},{"id":"2602581423","title":"Jasper Therapeutics, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602581423?lang=zh_cn&edition=full","pubTime":"2026-01-09 23:51","pubTimestamp":1767973877,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日23时51分，Jasper Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Novabay Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Zentalis Pharmaceuticals, Inc.涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为616.55%、54.89%、38.68%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Gri Bio, Inc.，振幅分别为38.05%、35.11%、30.25%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109235117a4b1079b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109235117a4b1079b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"1141548214","title":"Jasper Therapeutics公布Briquilimab治疗慢性自发性荨麻疹研究积极更新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1141548214","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141548214?lang=zh_cn&edition=full","pubTime":"2026-01-08 20:03","pubTimestamp":1767873820,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics最新发布了其研究性药物Briquilimab在慢性自发性荨麻疹治疗领域的积极更新数据。该数据显示，Briquilimab在临床试验中表现出显著疗效，为患者带来了新的治疗希望。\n研究结果进一步验证了Briquilimab在改善慢性自发性荨麻疹症状方面的潜力，标志着Jasper Therapeutics在该疾病治疗领域取得重要进展。这些数据将支持公司后续的临床开发计划，并为患者提供更多治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"1133790495","title":"Jasper Therapeutics任命Jeet Mahal出任首席执行官，引领临床发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1133790495","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133790495?lang=zh_cn&edition=full","pubTime":"2026-01-08 05:32","pubTimestamp":1767821531,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics正式宣布，任命Jeet Mahal担任公司首席执行官一职，他将主导公司下一阶段的临床发展战略与业务增长。这一重要人事变动标志着Jasper Therapeutics在推进其创新疗法研发进程中迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"gpt_icon":0},{"id":"1146489069","title":"Jasper Therapeutics：Briquilimab在研究中耐受性良好，显示出有利的安全性概况","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489069","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146489069?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:00","pubTimestamp":1764676850,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics：Briquilimab在研究中耐受性良好，显示出有利的安全性概况","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"1112115488","title":"Jasper Therapeutics公布Etesian研究中Briquilimab在哮喘治疗中的积极初步数据及Beacon研究内部调查发现","url":"https://stock-news.laohu8.com/highlight/detail?id=1112115488","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112115488?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:00","pubTimestamp":1764676849,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics公布Etesian研究中Briquilimab在哮喘治疗中的积极初步数据及Beacon研究内部调查发现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"1110443782","title":"Jasper Therapeutics 完成内部 Beacon 研究调查，未发现药品使用偏差或问题","url":"https://stock-news.laohu8.com/highlight/detail?id=1110443782","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110443782?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:00","pubTimestamp":1764676848,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics 完成内部 Beacon 研究调查，未发现药品使用偏差或问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"2583536900","title":"Jasper Therapeutics, Inc.盘中异动 下午盘快速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583536900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583536900?lang=zh_cn&edition=full","pubTime":"2025-11-13 02:31","pubTimestamp":1762972304,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日02时31分，Jasper Therapeutics, Inc.股票出现异动，股价大幅拉升5.88%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Leap Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Yd Bio Ltd C/Wts 28/08/2030涨幅较大，Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为6832.72%、1055.70%、617.42%，振幅较大的相关个股有Leap Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Salarius Pharmaceuticals, Inc.，振幅分别为350.86%、76.39%、62.24%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113023144a6f50bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113023144a6f50bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","JSPR","BK4007"],"gpt_icon":0},{"id":"2570202013","title":"Jasper Therapeutics, Inc.盘中异动 快速上涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570202013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570202013?lang=zh_cn&edition=full","pubTime":"2025-09-25 21:34","pubTimestamp":1758807240,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日21时34分，Jasper Therapeutics, Inc.股票出现波动，股价快速上涨7.12%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Pepgen Inc.、Scisparc Ltd.、Plus Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Evaxion A/S、Pepgen Inc.较为活跃，换手率分别为1417.65%、697.90%、194.37%，振幅较大的相关个股有Scisparc Ltd.、Plus Therapeutics, Inc.、Pepgen Inc.，振幅分别为18.28%、16.92%、15.04%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925213400a69dcea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925213400a69dcea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"1111900861","title":"Jasper Therapeutics盘后股价下跌9.7%，宣布拟公开发行普通股、预付权证及普通权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1111900861","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111900861?lang=zh_cn&edition=full","pubTime":"2025-09-19 04:25","pubTimestamp":1758227116,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics在盘后交易中股价下跌9.7%，该公司同时宣布计划进行一项公开发行，包括普通股、预付权证和普通权证的发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"1163623490","title":"Jasper Therapeutics宣布拟进行普通股、预付费认股权证和普通认股权证公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1163623490","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163623490?lang=zh_cn&edition=full","pubTime":"2025-09-19 04:09","pubTimestamp":1758226156,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics宣布拟进行普通股、预付费认股权证和普通认股权证公开发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"2518276252","title":"Jasper Therapeutics, Inc.盘中异动 早盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276252?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:19","pubTimestamp":1741616350,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时19分，Jasper Therapeutics, Inc.股票出现异动，股价急速下挫5.03%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3368.59%、714.84%、409.25%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、38.03%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221910abf30e40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221910abf30e40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2517437288","title":"Jasper Therapeutics, Inc.2024财年实现净利润-71.27百万美元，同比减少10.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517437288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517437288?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363246,"startTime":"0","endTime":"0","summary":"3月8日，Jasper Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-71.27百万美元，同比减少10.55%；其中营业收入为0.00美元，每股基本收益为-4.89美元。从资产负债表来看，Jasper Therapeutics, Inc.总负债15.96百万美元，其中短期债务1.09百万美元，资产负债比为5.01，流动比率为4.98。机构评级：截至2025年3月8日，当前有10家机构对Jasper Therapeutics, Inc.目标价做出预测，其中目标均价为59.30美元，其中最低目标价为38.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000145a2647ee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000145a2647ee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JSPR"],"gpt_icon":0},{"id":"2517716198","title":"Jasper Therapeutics, Inc.盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517716198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517716198?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:10","pubTimestamp":1741281012,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时10分，Jasper Therapeutics, Inc.股票出现异动，股价快速跳水5.46%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Plus Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为3143.16%、2633.05%、219.17%，振幅较大的相关个股有Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为105.20%、71.44%、68.33%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307011012989ed155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307011012989ed155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","JSPR","LENZ"],"gpt_icon":0},{"id":"2517948821","title":"Jasper Therapeutics, Inc.盘中异动 快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948821?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:41","pubTimestamp":1741185681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时41分，Jasper Therapeutics, Inc.股票出现异动，股价急速上涨5.06%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为418.31%、265.39%、199.90%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.，振幅分别为23.90%、20.71%、19.74%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224121989d4821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224121989d4821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2516637345","title":"Jasper Therapeutics, Inc.盘中异动 早盘股价大涨5.40%报6.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637345?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012385,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Jasper Therapeutics, Inc.股票出现波动，股价急速拉升5.40%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.50%、28.35%、23.89%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Bioxcel Therapeutics, Inc.，振幅分别为21.22%、19.25%、10.82%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223306989a0fd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223306989a0fd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","JSPR"],"gpt_icon":0},{"id":"2516107374","title":"Jasper Therapeutics, Inc.盘中异动 临近午盘股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516107374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516107374?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:36","pubTimestamp":1740760614,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时36分，Jasper Therapeutics, Inc.股票出现异动，股价快速上涨5.29%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Bioxcel Therapeutics, Inc.、Camp4 Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2923.76%、491.17%、364.17%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、46.60%、43.95%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301003655abe107fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301003655abe107fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","JSPR","LENZ"],"gpt_icon":0},{"id":"1173290621","title":"Jasper Therapeutics第四季度每股收益$(1.62)，未达预期$(1.23)","url":"https://stock-news.laohu8.com/highlight/detail?id=1173290621","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173290621?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:24","pubTimestamp":1740662671,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics报告季度亏损为每股$，较分析师一致预期的每股$低31.71%。与去年同期每股$的亏损相比，这一结果下降了8%。以上内容来自Benzinga Earnings专栏，原文如下：$Jasper Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 31.71 percent. This is a 8 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jasper Therapeutics第四季度每股收益$(1.62)，未达预期$(1.23)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR"],"gpt_icon":0},{"id":"2514867429","title":"Jasper Therapeutics, Inc.盘中异动 临近收盘股价大涨5.04%报5.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514867429?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:55","pubTimestamp":1740603338,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时55分，Jasper Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6948.43%、373.08%、270.03%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为201.69%、81.11%、70.39%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270455389893ef35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270455389893ef35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2513720574","title":"Jasper Therapeutics, Inc.盘中异动 早盘急速下跌5.54%报5.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720574?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:06","pubTimestamp":1740409561,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时06分，Jasper Therapeutics, Inc.股票出现波动，股价急速下跌5.54%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为163.64%、71.51%、25.97%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230601abdb166e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230601abdb166e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","JSPR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0296},{"period":"3month","weight":-0.2599},{"period":"6month","weight":-0.4922},{"period":"1year","weight":-0.7561},{"period":"ytd","weight":-0.2842}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jasper Therapeutics, Inc.于2019年8月13日在特拉华州成立。该公司是一家临床阶段的生物技术公司，致力于通过针对肥大和造血干细胞的疗法实现治疗。该公司专注于开发和商业化更安全、更有效的治疗药物，用于治疗慢性自发性荨麻疹、低至中度风险骨髓增生异常综合征等疾病，以及干细胞移植和离体基因治疗的新型调理方案，这是一种在移植前在体外对细胞进行基因操作的技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.285776},{"month":2,"riseRate":0.428571,"avgChangeRate":0.093912},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.018323},{"month":4,"riseRate":0.5,"avgChangeRate":-0.048363},{"month":5,"riseRate":0.833333,"avgChangeRate":0.048413},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094073},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.099771},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007485},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.2127},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.027786},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.069737},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008174}],"exchange":"NASDAQ","name":"Jasper Therapeutics","nameEN":"Jasper Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jasper Therapeutics(JSPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jasper Therapeutics(JSPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jasper Therapeutics,JSPR,Jasper Therapeutics股票,Jasper Therapeutics股票老虎,Jasper Therapeutics股票老虎国际,Jasper Therapeutics行情,Jasper Therapeutics股票行情,Jasper Therapeutics股价,Jasper Therapeutics股市,Jasper Therapeutics股票价格,Jasper Therapeutics股票交易,Jasper Therapeutics股票购买,Jasper Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jasper Therapeutics(JSPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jasper Therapeutics(JSPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}